Loading clinical trials...
Loading clinical trials...
An Adaptive, Randomized, Double-blind, Parallel-controlled Clinical Trial of Yinhu Qingwen Granula for the Treatment of Severe CoVID-19
Conditions
Interventions
Yinhu Qingwen Granula
Yin Hu Qing Wen Granula(low does)
+1 more
Locations
4
China
Wuhan No.7 Hospital/Jizhong Energy Fengfeng Group Hospital
Wuhan, Hubei, China
Wuhan No.7 Hospital/North China University of Science and Technology Affiliated Hospital
Wuhan, Hubei, China
Zhongnan Hospital of Wuhan University/Tanshan People's Hospital
Wuhan, Hubei, China
Wuhan Leishenshan (Thunder God Mountain) Hospital/The First Affiliated Hospital of Dalian Medical University
Wuhan, Hubei, China
Start Date
November 1, 2021
Primary Completion Date
December 1, 2022
Completion Date
April 1, 2023
Last Updated
July 7, 2021
NCT06082518
NCT07221162
NCT06631287
NCT06679140
NCT06417762
NCT03830320
Lead Sponsor
Zhong Wang
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions